chr12-32755771-G-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001040436.3(YARS2):​c.104C>A​(p.Ala35Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,613,946 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 41 hom. )

Consequence

YARS2
NM_001040436.3 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.514
Variant links:
Genes affected
YARS2 (HGNC:24249): (tyrosyl-tRNA synthetase 2) This gene encodes a mitochondrial protein that catalyzes the attachment of tyrosine to tRNA(Tyr). Mutations in this gene are associated with myopathy with lactic acidosis and sideroblastic anemia type 2 (MLASA2). [provided by RefSeq, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041893423).
BP6
Variant 12-32755771-G-T is Benign according to our data. Variant chr12-32755771-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 215417.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=3}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00209 (319/152366) while in subpopulation SAS AF= 0.018 (87/4832). AF 95% confidence interval is 0.015. There are 1 homozygotes in gnomad4. There are 170 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 41 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
YARS2NM_001040436.3 linkuse as main transcriptc.104C>A p.Ala35Asp missense_variant 1/5 ENST00000324868.13 NP_001035526.1 Q9Y2Z4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
YARS2ENST00000324868.13 linkuse as main transcriptc.104C>A p.Ala35Asp missense_variant 1/51 NM_001040436.3 ENSP00000320658.8 Q9Y2Z4
YARS2ENST00000548490.1 linkuse as main transcriptn.26C>A non_coding_transcript_exon_variant 1/55 ENSP00000447710.1 H0YHS6
ENSG00000286950ENST00000666291.1 linkuse as main transcriptn.262G>T non_coding_transcript_exon_variant 1/1

Frequencies

GnomAD3 genomes
AF:
0.00211
AC:
321
AN:
152248
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000820
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0182
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00222
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00380
AC:
953
AN:
250920
Hom.:
11
AF XY:
0.00457
AC XY:
621
AN XY:
135810
show subpopulations
Gnomad AFR exome
AF:
0.000619
Gnomad AMR exome
AF:
0.000636
Gnomad ASJ exome
AF:
0.00656
Gnomad EAS exome
AF:
0.000435
Gnomad SAS exome
AF:
0.0176
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00238
Gnomad OTH exome
AF:
0.00392
GnomAD4 exome
AF:
0.00301
AC:
4396
AN:
1461580
Hom.:
41
Cov.:
33
AF XY:
0.00338
AC XY:
2458
AN XY:
727090
show subpopulations
Gnomad4 AFR exome
AF:
0.00149
Gnomad4 AMR exome
AF:
0.000715
Gnomad4 ASJ exome
AF:
0.00582
Gnomad4 EAS exome
AF:
0.000731
Gnomad4 SAS exome
AF:
0.0166
Gnomad4 FIN exome
AF:
0.000696
Gnomad4 NFE exome
AF:
0.00212
Gnomad4 OTH exome
AF:
0.00417
GnomAD4 genome
AF:
0.00209
AC:
319
AN:
152366
Hom.:
1
Cov.:
33
AF XY:
0.00228
AC XY:
170
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.000817
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.00576
Gnomad4 EAS
AF:
0.000580
Gnomad4 SAS
AF:
0.0180
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.00220
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00235
Hom.:
0
Bravo
AF:
0.00169
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00209
AC:
18
ExAC
AF:
0.00399
AC:
484
Asia WGS
AF:
0.0150
AC:
53
AN:
3478
EpiCase
AF:
0.00240
EpiControl
AF:
0.00219

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 18, 2017- -
Hereditary Sideroblastic Anemia with Myopathy and Lactic Acidosis Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 12, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Myopathy, lactic acidosis, and sideroblastic anemia 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
YARS2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 13, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
10
DANN
Benign
0.75
DEOGEN2
Benign
0.18
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.055
N
LIST_S2
Benign
0.44
T
MetaRNN
Benign
0.0042
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.7
L
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.11
Sift
Benign
0.060
T
Sift4G
Benign
0.45
T
Polyphen
0.0010
B
Vest4
0.29
MVP
0.39
MPC
0.71
ClinPred
0.0043
T
GERP RS
0.80
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.12
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149447502; hg19: chr12-32908705; API